PortfoliosLab logo
MTD vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MTD and NVO is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

MTD vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mettler-Toledo International Inc. (MTD) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

MTD:

36.94%

NVO:

52.39%

Max Drawdown

MTD:

-2.54%

NVO:

-6.18%

Current Drawdown

MTD:

-1.87%

NVO:

-4.85%

Fundamentals

Market Cap

MTD:

$22.47B

NVO:

$296.96B

EPS

MTD:

$40.00

NVO:

$3.56

PE Ratio

MTD:

27.02

NVO:

18.47

PEG Ratio

MTD:

3.14

NVO:

1.00

PS Ratio

MTD:

5.87

NVO:

0.98

PB Ratio

MTD:

3.98K

NVO:

13.79

Total Revenue (TTM)

MTD:

$3.83B

NVO:

$303.14B

Gross Profit (TTM)

MTD:

$2.29B

NVO:

$255.65B

EBITDA (TTM)

MTD:

$1.20B

NVO:

$113.24B

Returns By Period


MTD

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

NVO

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MTD vs. NVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MTD
The Risk-Adjusted Performance Rank of MTD is 3030
Overall Rank
The Sharpe Ratio Rank of MTD is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of MTD is 2828
Sortino Ratio Rank
The Omega Ratio Rank of MTD is 2929
Omega Ratio Rank
The Calmar Ratio Rank of MTD is 3232
Calmar Ratio Rank
The Martin Ratio Rank of MTD is 3333
Martin Ratio Rank

NVO
The Risk-Adjusted Performance Rank of NVO is 55
Overall Rank
The Sharpe Ratio Rank of NVO is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 55
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 66
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 66
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MTD vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mettler-Toledo International Inc. (MTD) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

MTD vs. NVO - Dividend Comparison

MTD has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.45%.


TTM20242023202220212020201920182017201620152014
MTD
Mettler-Toledo International Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
2.45%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

MTD vs. NVO - Drawdown Comparison

The maximum MTD drawdown since its inception was -2.54%, smaller than the maximum NVO drawdown of -6.18%. Use the drawdown chart below to compare losses from any high point for MTD and NVO. For additional features, visit the drawdowns tool.


Loading data...

Volatility

MTD vs. NVO - Volatility Comparison


Loading data...

Financials

MTD vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Mettler-Toledo International Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20212022202320242025
883.74M
78.09B
(MTD) Total Revenue
(NVO) Total Revenue
Values in USD except per share items

MTD vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Mettler-Toledo International Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%85.0%20212022202320242025
59.5%
83.5%
(MTD) Gross Margin
(NVO) Gross Margin
MTD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported a gross profit of 525.88M and revenue of 883.74M. Therefore, the gross margin over that period was 59.5%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a gross profit of 65.20B and revenue of 78.09B. Therefore, the gross margin over that period was 83.5%.

MTD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported an operating income of 236.73M and revenue of 883.74M, resulting in an operating margin of 26.8%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported an operating income of 38.79B and revenue of 78.09B, resulting in an operating margin of 49.7%.

MTD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported a net income of 163.59M and revenue of 883.74M, resulting in a net margin of 18.5%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a net income of 29.03B and revenue of 78.09B, resulting in a net margin of 37.2%.